Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2025 Earnings Call Transcript November 5, 2025
Operator: “
Jack Khattar: “
Timothy Dec: “
Peter Vozzo: “
Lin Tsai: ” Jefferies LLC, Research Division
Annabel Samimy: ” Stifel, Nicolaus & Company, Incorporated, Research Division
David Amsellem: ” Piper Sandler & Co., Research Division
Pavan Patel: ” BofA Securities, Research Division
Stacy Ku: ” TD Cowen, Research Division
Operator: Good afternoon, and welcome to the Supernus Pharmaceuticals...
